California 2025-2026 Regular Session

California Assembly Bill AB957

Introduced
2/20/25  
Refer
3/28/25  
Report Pass
4/8/25  
Refer
4/8/25  
Report Pass
4/24/25  
Refer
4/29/25  
Refer
5/7/25  
Report Pass
5/23/25  
Engrossed
6/2/25  
Refer
6/3/25  

Caption

An act to amend Section 22973.

Impact

If enacted, this legislation is expected to alter the landscape of tobacco product availability within the state significantly. Pharmacies, typically perceived as health-centric establishments, will no longer be able to sell tobacco products, effectively removing a point of access for consumers. Additionally, this bill will prevent the Department of Tax and Fee Administration from issuing licenses to pharmacies for the sale of these products. Given that violations will result in misdemeanor charges, the bill establishes a state-mandated local program pertaining to enforcement and compliance.

Summary

Assembly Bill 957, introduced by Assembly Member Ortega, seeks to amend the existing regulations regarding the sale of cigarettes and tobacco products by prohibiting pharmacies from engaging in their retail sale. This law arises from the provisions outlined in the Cigarette and Tobacco Products Licensing Act of 2023, which mandates that retailers must hold an appropriate license from the State Board of Equalization to sell these products. The intent behind AB 957 is to mitigate access to tobacco products through pharmacies, which are often associated with health and wellness, thus reinforcing public health efforts to reduce tobacco consumption.

Sentiment

The sentiment surrounding AB 957 appears to be largely positive among proponents of public health, as the bill is viewed as a progressive step towards reducing tobacco use within vulnerable populations. Supporters argue that by removing the sale of cigarettes from pharmacies, it aligns the operations of these healthcare providers with their fundamental goal of promoting health. Conversely, there may be some contention among retail pharmacies, as this segment of the industry relies on a diverse product offering, and the restriction could potentially impact their revenue streams.

Contention

Notable points of contention include concerns raised by retail pharmacy advocates who fear that the prohibition on cigarette sales may lead to revenue losses. Additionally, the wording around state reimbursement for local costs associated with the enforcement of this bill has sparked discussions among legislators. The bill clarifies that no state reimbursement will be required due to the nature of the imposed restrictions and the definitions related to crime under state law. This aspect has led to debates on the financial ramifications for local agencies involved in enforcement.

Companion Bills

No companion bills found.

Previously Filed As

CA SB6

An act to amend Sections 11014.

CA AB1027

An act to amend Sections 26039.

CA AB968

An act to amend Sections 733, 2242.

CA AB116

An act to amend Sections 1276.

CA SB353

An act to amend Sections 17053.

CA SB540

An act to amend Sections 337 and 399.

CA AB1170

An act to amend Sections 205, 208, 1944, 2529.

CA AB80

An act to amend Sections 42968, 42968.

CA AB137

An act to amend Sections 1798.

CA AB1107

Cigarette and Tobacco Products Licensing Act of 2003: nitrous oxide: licensure.

Similar Bills

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.

AR SB475

To Establish The Pharmacy Services Administrative Organization Act; And To Regulate Pharmacy Services Administrative Organizations.

CA SB41

Pharmacy benefits.

AZ HB2813

Pharmacy benefits; workers' compensation

DE SB271

An Act To Amend Title 18 Of The Delaware Code Relating To Pharmacy Benefits Managers.

AZ HB2429

Pharmacy benefits; pharmacy management networks

AZ HB4124

Health insurance; pharmacy; reimbursement rates

CA AB910

Pharmacy benefit management.